Dindigul Farm Product Peer Comparison

BSE: 544201

₹36.98

₹-1.31 (-3.42%)

As on 22-Oct-2026IST

Market cap

₹90 Cr

Revenue (TTM)

₹62 Cr

P/E Ratio

24.3

P/B Ratio

2.6

Div. Yield

0 %

Edit

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene
Market cap (₹ Cr)	90	801	764	29,661	14,173
Revenue (₹ Cr)	62	383	1,768	2,250	3,813
Net Profit (₹ Cr)	-5.61	37.94	72.56	361.74	400.90
Net Margin (%)	-8.93	9.59	4.04	15.77	10.30
RoE (%)	-24.65	18.82	14.65	15.47	13.87
Price to Earnings	24.28	21.12	11.05	82.00	35.35
Price-To-Book	2.57	3.48	1.47	11.62	4.42

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene
Operating Revenue	62.05	324.93	1,006.42	1,694.57	2,839.30
Total Income	62.83	331.29	1,021.53	1,731.35	2,946.50
Total Expenditure	62.55	284.06	911.53	1,286.73	2,305.00
EBITDA	-0.51	40.87	94.88	407.84	534.30
Depreciation	1.87	8.77	13.55	138.57	80.20
EBIT	-2.37	32.10	81.33	269.27	454.10
Interest	2.89	3.95	37.25	78.34	22.00
Other Income	0.78	6.36	15.12	36.78	107.20
Exceptional Items	--	-0.80	--	--	--
Profit before Tax	-4.48	33.72	60.27	227.70	539.30
Provision for Tax	1.13	9.41	12.17	57.57	132.60
Profit after Tax	-5.61	24.31	48.10	170.13	406.70

Liabilities (₹ Cr)

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene
Shareholder's Funds	35.21	194.18	440.70	2,128.35	2,615.60
Minority Interest	--	--	15.80	--	--
Non-Current Liabilities	15.80	12.39	9.41	321.62	56.00
Current Liabilities	13.32	52.66	610.41	759.14	564.50
Total Liabilities	64.56	261.36	1,076.32	3,209.12	3,325.90

Assets (₹ Cr)

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene
Non-Current Assets	22.53	75.09	150.60	1,677.96	706.10
Current Assets	41.81	184.14	925.72	1,531.16	2,530.00
Total Assets	64.56	261.36	1,076.32	3,209.12	3,325.90
Total Debt*	17.92	26.60	450.29	128.64	0.00
Net Current Assets	28.49	131.48	315.32	772.02	1,965.50
Contingent Liabilities	--	8.81	116.73	58.11	--

Cashflow (₹ Cr)

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene
Cash From Operating Activities	-12.43	38.47	-111.93	314.05	441.90
Cash Flow from Investing Activities	-11.19	-22.34	-34.99	-536.67	-682.70
Cash from Financing Activities	23.61	-19.26	55.55	301.43	287.50
Net Cash Inflow / Outflow	0.00	-3.13	-91.36	78.81	46.70

Ratios

Profitability Ratios

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene
ROCE (%)	-3.86	17.37	11.82	15.53	25.24
ROE (%)	-24.65	14.06	11.50	11.02	20.45
ROA (%)	-9.59	9.58	4.77	6.17	14.24
EBIT Margin (%)	0.45	14.53	10.93	26.24	22.59
Net Margin (%)	-8.93	7.34	4.71	9.83	13.80
Cash Profit Margin (%)	-6.04	9.96	6.01	18.20	17.15

Growth Ratios

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene
Revenue Growth (%)	-27.46	9.14	-27.06	15.66	9.64
EBIT Growth (%)	-97.87	50.38	-10.30	40.60	10.28
Net Profit Growth (%)	-164.22	98.99	-35.27	105.45	20.79
EPS Growth (%)	-147.27	99.00	-33.68	74.12	11.96
Book Value Growth (%)	240.67	11.19	11.26	120.22	84.55

Valuation Ratios

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene
Price / Earnings	0.00	0.00	21.12	93.36	34.05
Price / Book Value	1.64	0.00	2.23	7.48	5.37
Dividend Yield (%)	0.00	--	0.00	0.00	0.35
EV/EBITDA	274.16	0.63	12.63	34.97	21.00
Market Cap (₹ Cr)	57.83	0.00	980.95	15,882.87	13,848.97

Solvency Ratios

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene
Debt to Equity	0.51	0.14	1.02	0.06	0.00
Short term debt to equity ratio	0.04	0.08	1.01	0.06	--
Current Ratio	3.14	3.50	1.52	2.02	4.48
Quick Ratio	2.56	2.33	0.59	1.86	4.48
Interest Coverage	-0.55	9.54	2.62	3.91	25.51

Operating Efficiency Ratios

	Dindigul Farm Product	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene
Debtors to sales (%)	6.18	18.41	19.85	20.94	26.46
Asset Turnover	1.06	1.31	1.02	0.61	0.99
Receivable days	18.94	59.54	68.51	65.73	89.95
Inventory Days	65.45	77.26	175.65	22.19	0.00
Payable days	132.39	38.90	65.49	180.62	--
Cash Conversion Cycle	-47.99	97.90	178.67	-92.70	--

Annual
Quarterly